Comprehensive next-generation sequencing may be informative in such cases, with the finding of the low mutation burden, MEN1 or EIF1AX mutations, and the lack of RB1 and TP53 alterations being supportive of carcinoid tumor diagnosis27. This evidence concerns the gene RB1 and carcinoid tumor.